Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × sintilimab × 90 days × Clear all

NCT05549037 2026-06-03

LungTIME-C01

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT07603661 2026-05-22

Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07309952 2026-04-30

SACTION 2501

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung